30-10-2026 16:10 via Drugs.com - News for Health Professionals

Hypofractionated Postmastectomy RT Noninferior to Conventional PMRT

FRIDAY, Oct. 30, 2026 -- A 16-week course of hypofractionated postmastectomy radiation therapy (PMRT) is safe and noninferior to conventional PMRT, according to a study published online Oct. 12 in the Journal of Clinical Oncology.
Matthew M. Poppe...

Monthly News Roundup - October 2026

Living Alone Linked to Increased Risk for Death From Multiple Causes

Factors ID'd for Detecting Polyps on IBD Surveillance Colonoscopies

Patients With Psoriasis Have Increased Risks for Cataracts, Cataract Surgery

Surgical Recurrence Less Frequent With Laparoscopic Surgery for Crohn Disease

Infectious Diseases Society of America, Oct. 21-24

High-Volume Injections Not Beneficial in Midportion Achilles Tendinopathy

Childhood Measles Vaccination Rates Down Globally

American Society of Anesthesiologists, Oct. 16 to 20

New Swab Test Could Spare Some Women A Painful Biopsy For Endometrial Cancer

Omega-3s Might Improve Survival In Advanced Cancer, Trial Finds

Heated Tobacco: A New Trend That Is Raising Heart Health Concerns

Want to Lose Weight? Why Mixing Cardio And Strength Training Beats Any Single Workout

One-Third Of Young Adults Use AI Chatbots To Seek One Type Of Illicit Info

Desktop versie

Hypofractionated Postmastectomy RT Noninferior to Conventional PMRT

Pharmaceutical news